Literature DB >> 22648280

The effect of operational stressors on ibuprofen pharmacokinetics.

Cathy Boscarino1, Andrea N Edginton, Henry Peng, K Wayne Riggs, András Szeitz, Bob Cheung.   

Abstract

PURPOSE: To determine whether two of the major operational stressors associated with military missions in Afghanistan: dry heat and long durations of soldier patrol (SP), alter the pharmacokinetics of ibuprofen.
METHODS: Thirteen healthy and physically fit participants (19-32 years) were randomized to a four-arm crossover study, as follows: Arm 4 consisted of a simulated 2.5 h SP on a treadmill set at 4.5 km/h, 2% incline (15-min walk/5-min rest cycle) in a climatic chamber set to 42°C, 9% relative humidity. Arm 3 was similar to arm 4 but at room temperature, and arms 1 and 2 were sham SP to 3 and 4, respectively. For the final 2.5 h, participants remained in a semi-supine position. Each participant orally administered one 400-mg Advil Liqui-Gel® capsule. Blood samples were drawn over time and analyzed for (R)-ibuprofen and (S)-plasma ibuprofen concentrations using UPLC/MS/MS. Concentration-time data were analyzed by compartmental methods.
RESULTS: Exercise significantly decreased the t(1/2abs) (h) of (S)-ibuprofen (0.26 to 0.17; p = 0.015) and T(max) (h) for both (R)-ibuprofen (0.97 to 0.73; p = 0.008) and (S)-ibuprofen (1.13 to 0.84; p = 0.005). Values for t(lag) (h) also decreased with exercise for both (R)-ibuprofen (0.38 to 0.22; p = 0.005), and (S)-ibuprofen (0.39 to 0.23; p = 0.001).
CONCLUSIONS: Exercise stress had a significant impact on the absorption profile of (R)- and (S)-ibuprofen. Excessive self-administration rate and dose may not be due to the military operational stressors of heat and soldier presence patrol.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22648280     DOI: 10.1007/s00228-012-1307-5

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  37 in total

1.  Gastrointestinal profile of symptomatic athletes at rest and during physical exercise.

Authors:  Michiel A van Nieuwenhoven; Fred Brouns; Robert-Jan M Brummer
Journal:  Eur J Appl Physiol       Date:  2003-11-22       Impact factor: 3.078

2.  Stereoselective disposition of ibuprofen enantiomers in man. 1985.

Authors:  E J D Lee; K Williams; R Day; G Graham; D Champion
Journal:  Br J Clin Pharmacol       Date:  2004-12       Impact factor: 4.335

3.  Molecular cloning and expression of a 2-arylpropionyl-coenzyme A epimerase: a key enzyme in the inversion metabolism of ibuprofen.

Authors:  C Reichel; R Brugger; H Bang; G Geisslinger; K Brune
Journal:  Mol Pharmacol       Date:  1997-04       Impact factor: 4.436

4.  Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-04

5.  Drugs--some basic concepts.

Authors:  G D Sweeney
Journal:  Med Sci Sports Exerc       Date:  1981       Impact factor: 5.411

6.  The impact of lag time on the estimation of pharmacokinetic parameters. I. One-compartment open model.

Authors:  N G Nerella; L H Block; P K Noonan
Journal:  Pharm Res       Date:  1993-07       Impact factor: 4.200

7.  Human pharmacology of a performance-enhancing dietary supplement under resting and exercise conditions.

Authors:  Christine A Haller; Minjing Duan; Peyton Jacob; Neal Benowitz
Journal:  Br J Clin Pharmacol       Date:  2008-03-13       Impact factor: 4.335

8.  Psychophysical bases of perceived exertion.

Authors:  G A Borg
Journal:  Med Sci Sports Exerc       Date:  1982       Impact factor: 5.411

9.  Pharmacokinetics and bioinversion of ibuprofen enantiomers in humans.

Authors:  H Cheng; J D Rogers; J L Demetriades; S D Holland; J R Seibold; E Depuy
Journal:  Pharm Res       Date:  1994-06       Impact factor: 4.200

10.  Enantiospecific effects of cytochrome P450 2C9 amino acid variants on ibuprofen pharmacokinetics and on the inhibition of cyclooxygenases 1 and 2.

Authors:  Julia Kirchheiner; Ingolf Meineke; Georg Freytag; Christian Meisel; Ivar Roots; Jürgen Brockmöller
Journal:  Clin Pharmacol Ther       Date:  2002-07       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.